The UK-US pharma deal removes tariffs, boosts NHS access to innovative medicines, and drives significant life-sciences investment, safeguarding patients and industry growth.
Andrew Nunn, Professor of Epidemiology in the Medical Research Council Clinical Trials Unit at UCL, analyses different tuberculosis drug development regimens.
As the first alternative for non-invasive treatment of kidney stones, ultrasound bursts can actually break up kidney stones – making it easier for them to pass on their own.
A new study on HIV medication treatment discovered persistent disparities between sex and age, potentially subjecting women to worse HIV treatment outcomes on the drug dolutegravir.
A new study, published in AIDS and Behavior, finds that healthcare providers still have some social bias about who should be given PrEP - the HIV prevention drug.
Doris-Ann Williams MBE, CEO, BIVDA, calls for increased community testing as a way to clear the NHS backlog and deal with the increasing number of people who are living with undiagnosed diseases in the UK.
A new study, demonstrating how circadian rhythms in heart cells alter daily heart function, may explain why shift workers are vulnerable to heart complications.
